top of page


Reverse Engineering
of Digital Measures
A conference on patient-centric digital evidence.

by ETH Zürich and FNIH. 

Zürich, Switzerland
15-16 September 2022
ETH Zürich, HG Main Building 


2 Days 4 Use Cases
Go to Agenda for detailed information 

Thu.15.09.2022 - 11:00-22.00 CET 

Qualification of New Digital Evidence

Use Case 1: MOBILISE-D:

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Use Case 2: IDEA FAST:

Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases

Fri. 16.09.2022 - 11:00-22:00 CET

From Efficacy to Effectiveness

Use Case 3: Roche DHTs for SMA:

Digital Health Technologies to better measure outcomes in Spinal Muscular Atrophy

Use Case 4: SCZ:

The Accelerating Medicines Partnership® Program – Schizophrenia (AMP® SCZ)

* If you can't join the conference you can watch the live stream for participation.

The Conference

About the conference

What is it about?

In February 2020, the FNIH Biomarkers Consortium hosted a conference to examine progress in, and establish a path forward for, incorporating remote digital monitoring into clinical evidence generation. This highly interactive, collaborative meeting crystalised and catalysed much of the recent progress we have seen in digital measurement of health. Nearly three years later, we are launching the next iteration of the meeting, to be hosted by the ETH in Zurich, Switzerland. One of the key achievements was an increased awareness of how patient centricity is critical for success in developing new digital measures.

Meeting Overview and Aims

Co-organised with the FNIH Biomarkers Consortium, the meeting is titled “Reverse Engineering of Digital Measures.” It will build on the success of the first meeting, sharing the experiences of four extended case studies and examining progress, opportunities and challenges. The interactive case studies will involve regulators, industry, patients and innovators and emphasise how patient centricity is shaping the development and validation of new evidence across settings including regulatory interactions, reimbursement and product development.

Over two full afternoons, we will explore how human-centered, holistic, evidence-based science is being put into practice and examine how this is shaping regulatory and payer interactions, patient and human engagement, product development and embedding of digital measures into decision making throughout care delivery.


Jörg Goldhahn and Steve Hoffmann

The meeting will be in presence, following current Swiss hygiene guidelines, with live streaming. We are really hoping as many of you as possible will be able to attend, we want to continue the robust discussion and exchange of ideas started in the first meeting.


Patients, participants, caregiver are the ultimate stakeholders for our work — we all talk about engaging them, how far are we from achieving that? What are best practices and shining examples (or failures)?


Integration across health services, telemedicine, etc, how is our understanding of disease changing? Efforts at breaking down silos across treatment and data sources. Examples of integrated care, personalized care, predictive/preventative interventions, etc.


Demonstrating fit for purpose (regulators), treatment value (insurers) and business value (pharma, startups)

Information and Papers from the first meeting, hosted by the FNIH in 2020:

• Meeting Overview including agenda andsession recordings
• Remote digital monitoring in clinical trials in the time of COVID-19. 
   Goldsack JC, et al. Nature Reviews Drug Discovery (2020)
• Remote Digital Monitoring for Medical Product Development.
   Izmailova EA, et al. Clin Transl Sci (2020)



Use Cases








Steve Hoffmann


Elena Izmailova  Koneksa Health 

Jörg Goldhahn

ETH Zürich

Ursula Costa

Basel Area Swiss

Foteini Orfaniotou


Thanneer Mailai Perumal Roche

Francesca Cormack

Cambridge Cognition

Wojtek Piwko


Ieuan Clay


Beatrix Vereijken


Justin Baker


David Nobbs


Arne Müller


Lada Leyens 


Thorsten Vetter


John Varaklis


Dana Connors


John Torous


Medical School

 Christopher Bull 

Newcastle University

Tova Gur Arieh

Nitzan Association

Clemens Becker

Robert Bosch Krankenhaus

Alison Keogh

Trinity College Dublin

Wim Dartee


Andrea Cereatti

Politecnico di Torino

General Co-Chairs
Jörg Goldhahn, ETH Zürich
Steve Hoffmann, FNIH

Technical Programme Co-Chairs 
Ieuan Clay, Vivosense
Laurenz Baltzer, ETH Zürich

Steering Committee
Jörg Goldhahn, ETH Zürich
Steve Hoffmann, FNIH
Dana Connors, FNIH
Thorsten Vetter, EMA
Peter Groenen, Idorsia
John Varaklis, PhysIQ

Organizing Committee 
Alexandra Bündner, ETH Zürich
Anja Finkel, ETH Zürich
Anja Rüdisüli, ETH Zürich
Past Events


Venue Reverse Engineering of Digital Measures Conference 15-16.09.22

bottom of page